Published
On May 12, the country's Drug Controller General of India (DCGI) has accepted the recommendation of the Subject Expert Committee and has approved the second and third clinical trials of the India Biotech's Corona Vaccine Covaxin. This clinical trial will be done in the age group of 2 to 18 years. Watch this news report to know more.
- Category
- Asia
- Tags
- Corona Crisis, Dcgi, covaxin approved in india
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
18:21
Corona Vaccine पर 'डबल खुशखबरी', Covishield और Covaxin को DCGI की ने दी मंजूरी | Breaking News
-
10:26
Covid-19 Vaccine: Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% Efficacy
-
03:04
Coronavirus Vaccine | Covaxin Recommended For Next Phase Of Trials For 2-18 Age Group: Report
-
17:09
Third phase trial results of Covaxin to release soon | Master Stroke
-
06:28
Politics gain heat after DCGI approves Corona vaccines
-
02:23
Bharat Biotech Enrols Over 25,000 Volunteers For Covaxin Phase 3 Trial
-
02:55
Covaxin 77.8% Effective In Phase 3 Trial Data: Sources
-
09:11
Covaxin Phase 1 Trial Clears Lancet Review, Phase 3 Trial Ongoing
-
49:46
Covaxin For Kids Soon? | Left, Right & Centre
-
07:53
Corona Crisis: Recommendations for trial of Bharat Biotech's vaccine for kids | India Chahta Hai
-
07:47
Covaxin Interim Results 'Encouraging', Phase 3 Trials To Continue: AIIMS Chief
-
09:31
Corona Crisis: Trial of 3rd dose of Covaxin begins in AIIMS
-
03:48
WHO Approves Bharat Biotech's Covaxin For Emergency Use
-
17:09
Third phase trial results of Covaxin to release soon | Master Stroke
-
02:59
Covaxin Phase 3 Data Shows 77.8% Efficacy, Says Lancet
-
09:36
Bhopal: Volunteer dies during 3rd phase Covaxin trial, Bharat Biotech issues clarification
-
15:01
Bharat Biotech की Covaxin का Trial Dose लेने वाले Anil Vij Corona Positive| Hindi News | Latest News
-
05:46
AMU Vice-Chancellor Registers Himself As First Volunteer Of Covaxin Phase-3 Trial
-
35:22
DCGI allows Phase II-III clinical trial of Covaxin on 2 to 18-years-old
-
02:17
Covid-19 Vaccine: Covaxin Phase 3 Trial Data Shared With Expert Panel Which Meets Today
-
20:09
Coronavirus: Facts Vs Myths | Covaxin Safe, Phase 3 Results Needed: Lancet
-
02:42
Covaxin Shows Interim Efficacy Of 81% In Phase 3 Results: Bharat Biotech
Loading...